Detail akcie Repro Med Syst online

Business Summary: KORU Medical Systems, Inc. is a medical technology company. The Company is focused on developing, manufacturing, and commercializing patient-centric large volume subcutaneous infusion solutions primarily for the subcutaneous drug delivery market. The Company is focused on its mechanical infusion products, the FREEDOM Infusion Systems (FREEDOM System), which include the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. The Company’s infusion devices work together as a system to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD) and chronic inflammatory demyelinating polyneuropathy (CIDP). The FREEDOM System operates at a lower pressure than an electrical, volumetric pump and maintains a balance between what a patient’s subcutaneous tissues can tolerate and what the system delivers.
Financial Summary: BRIEF: For the six months ended 30 June 2025, KORU Medical Systems Inc revenues increased 19% to $19.8M. Net loss decreased 53% to $1.4M. Revenues reflect Domestic Core segment increase of 16% to $14M, International Core segment increase of 35% to $4.6M, Domestic segment increase of 16% to $15.2M, International segment increase of 33% to $4.6M. Lower net loss reflects Research and development decrease of 12% to $2.3M (expense).